|
TECH | Bio-Techne Corp |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.25 |
| Leverage | 20.28% |
| Market Cap | $ 8.2B |
| PE | 99.93 |
| Dividend Yield | 0.62% |
| Profit | $ 81.8m |
| Margin | 6.74% |
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.